Analysis of arterial stiffness parameters in breast cancer patients undergoing combination anthracycline-containing chemotherapy
Open Access
- 16 May 2025
- journal article
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (4) , 4272
Abstract
Aim. To identify and analyze changes of arterial stiffness (AS) parameters in breast cancer patients undergoing combination anthracycline-containing chemotherapy (ACCT).Material and methods. Fifty women with verified breast cancer aged 46,7±7 years with indications for combined ACCT were assessed for AS (carotid-femoral pulse wave velocity (cfPWV) (m/s); cardio-ankle vascular index (CAVI); cardio-ankle pulse wave velocity (caPWV) (m/s); β-stiffness index, novel Russian Stelari and haStart indices) at 4 visits as follows: before ACCT, after 8-12, 20-24 and 48 weeks from the ACCT start.Results. A reliable decrease in cfPWV was revealed at visit 2 (7,48±1,51, pConclusion. In patients with breast cancer who underwent combined ACCT, an increase in cfPWV by 0,95 m/s per year was revealed, which indicates accelerated vascular wall aging and a possible increase in cardiovascular risk in this category of patients.Keywords
This publication has 24 references indexed in Scilit:
- Arterial Stiffness May Predict Subsequent Cancer Therapy-Related Cardiac Dysfunction in Breast Cancer PatientsCardiovascular Toxicology, 2024
- Prolonged impact of anti-cancer therapy on endothelial function and arterial stiffness in breast cancer patientsVascular Pharmacology, 2023
- Cytotoxic mechanisms of doxorubicin at clinically relevant concentrations in breast cancer cellsCancer Chemotherapy and Pharmacology, 2022
- Doxorubicin induces arterial stiffness: A comprehensive in vivo and ex vivo evaluation of vascular toxicity in miceToxicology Letters, 2021
- Adverse Vascular Functional and Structural Changes Secondary to Breast Cancer and its Treatments with Adjuvant Therapy: a Systematic ReviewSN Comprehensive Clinical Medicine, 2021
- BSE and BCOS Guideline for Transthoracic Echocardiographic Assessment of Adult Cancer Patients Receiving Anthracyclines and/or TrastuzumabJACC: Cardiooncology, 2021
- Clinical Pharmacokinetics of Paclitaxel Monotherapy: An Updated Literature ReviewClinical Pharmacokinetics, 2017
- Paclitaxel chemotherapy and vascular toxicity as assessed by flow-mediated and nitrate-mediated vasodilatationVascular Pharmacology, 2010
- Prediction of Cardiovascular Events and All-Cause Mortality With Arterial StiffnessJACC, 2010
- The immunopharmacology of paclitaxel (Taxol®), docetaxel (Taxotere®), and related agentsInternational Immunopharmacology, 2003